Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-18-001326
Filing Date
2018-03-06
Accepted
2018-03-06 17:05:14
Documents
117
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2234751z10-k.htm 10-K 2136586
2 EX-21.1 a2234751zex-21_1.htm EX-21.1 4505
3 EX-23.1 a2234751zex-23_1.htm EX-23.1 2030
4 EX-31.1 a2234751zex-31_1.htm EX-31.1 7621
5 EX-31.2 a2234751zex-31_2.htm EX-31.2 7624
6 EX-32.1 a2234751zex-32_1.htm EX-32.1 6052
13 G853692.JPG g853692.jpg GRAPHIC 159068
14 G581068.JPG g581068.jpg GRAPHIC 167408
15 G837974.JPG g837974.jpg GRAPHIC 146176
16 G104934.JPG g104934.jpg GRAPHIC 58892
17 G373135.JPG g373135.jpg GRAPHIC 67182
18 G946035.JPG g946035.jpg GRAPHIC 94072
19 G445373.JPG g445373.jpg GRAPHIC 62701
20 G942164.JPG g942164.jpg GRAPHIC 90124
21 G9679.JPG g9679.jpg GRAPHIC 83336
22 G27906.JPG g27906.jpg GRAPHIC 61644
23 G369527.JPG g369527.jpg GRAPHIC 47302
24 G56421.JPG g56421.jpg GRAPHIC 68837
25 G598784.JPG g598784.jpg GRAPHIC 29747
26 G104336.JPG g104336.jpg GRAPHIC 43246
  Complete submission text file 0001047469-18-001326.txt   13432589

Data Files

Seq Description Document Type Size
7 EX-101.INS bhvn-20171231.xml EX-101.INS 2856702
8 EX-101.SCH bhvn-20171231.xsd EX-101.SCH 87739
9 EX-101.CAL bhvn-20171231_cal.xml EX-101.CAL 61833
10 EX-101.DEF bhvn-20171231_def.xml EX-101.DEF 428764
11 EX-101.LAB bhvn-20171231_lab.xml EX-101.LAB 731650
12 EX-101.PRE bhvn-20171231_pre.xml EX-101.PRE 698301
Mailing Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38080 | Film No.: 18670789
SIC: 2834 Pharmaceutical Preparations